No more bitter pill, Mexico's Viagra is chewable
MEXICAN men who have difficulty swallowing Viagra pills will soon have a chewable version of Pfizer Inc's impotence drug.
Known as Viagra Jet, it was developed over four years in Mexico, where the company will start selling it from Monday.
The United States pharmaceutical company said on Thursday that the chewable form of the 13-year-old pale blue pill was developed in response to studies of the Mexican market, which is Viagra's biggest in Latin America after Brazil. "It's a new alternative for patients and doctors," said Beatriz Romero, Pfizer's marketing manager in Mexico. "The chewable format could appeal to patients, particularly those who can't swallow the tablets."
Pfizer said studies have shown that as many as 60 percent of people grind tablets or open capsules to make the contents easier to ingest.
About 6 million Mexican men suffer from impotence, according to a 2001 study published in the medical journal Revista Mexicana Urologia. Pfizer said it sells 3 million Viagra tablets a year in Mexico. According to research firm IMS Health, Viagra has about one third of the market share in Latin America's second biggest economy.
Viagra Jet is only available in Mexico, but the company may introduce it in other Latin American countries, depending upon local regulatory approval, Pfizer spokeswoman Karla Fuentes said.
Mexican sales of Viagra were just under US$55 million in 2010, according to IMS Health, while Pfizer reported global sales of the drug of US$1.93 billion. Despite these figures, Viagra sales never quite matched Wall Street's earlier hopes, in large part due to competition from Eli Lilly & Co's longer-acting Cialis brand.
Cialis posted sales of US$1.7 billion in 2010, up 9 percent on the previous year, while Viagra sales climbed 2 percent in the same period.
The development of Viagra Jet will not extend the drug's patent life beyond its 2012 expiration, Pfizer said.
Known as Viagra Jet, it was developed over four years in Mexico, where the company will start selling it from Monday.
The United States pharmaceutical company said on Thursday that the chewable form of the 13-year-old pale blue pill was developed in response to studies of the Mexican market, which is Viagra's biggest in Latin America after Brazil. "It's a new alternative for patients and doctors," said Beatriz Romero, Pfizer's marketing manager in Mexico. "The chewable format could appeal to patients, particularly those who can't swallow the tablets."
Pfizer said studies have shown that as many as 60 percent of people grind tablets or open capsules to make the contents easier to ingest.
About 6 million Mexican men suffer from impotence, according to a 2001 study published in the medical journal Revista Mexicana Urologia. Pfizer said it sells 3 million Viagra tablets a year in Mexico. According to research firm IMS Health, Viagra has about one third of the market share in Latin America's second biggest economy.
Viagra Jet is only available in Mexico, but the company may introduce it in other Latin American countries, depending upon local regulatory approval, Pfizer spokeswoman Karla Fuentes said.
Mexican sales of Viagra were just under US$55 million in 2010, according to IMS Health, while Pfizer reported global sales of the drug of US$1.93 billion. Despite these figures, Viagra sales never quite matched Wall Street's earlier hopes, in large part due to competition from Eli Lilly & Co's longer-acting Cialis brand.
Cialis posted sales of US$1.7 billion in 2010, up 9 percent on the previous year, while Viagra sales climbed 2 percent in the same period.
The development of Viagra Jet will not extend the drug's patent life beyond its 2012 expiration, Pfizer said.
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证:沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证:31120180004
- |
- 网络视听许可证:0909346
- |
- 广播电视节目制作许可证:沪字第354号
- |
- 增值电信业务经营许可证:沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.